GlassScriptPhysician profile
Aaron D Webel
NPI 1326452673
$3,162.81
in general payments reported to CMS, 2019-2025
10 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.39 · 2021: $502 · 2022: $1,077 · 2023: $696 · 2024: $363 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,107.84 | 2022-2025 | Xen Glaucoma Treatment System, Durysta |
| Sight Sciences, INC. | $654.33 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $538.65 | 2022-2025 | Hydrus Microstent, Voyager Dslt, Clareon |
| New World Medical,INC. | $261.15 | 2021-2024 | Clearpath, Streamline, Kahook Dual Blade |
| Allergan, INC. | $217.12 | 2020-2022 | |
| Ivantis, INC | $171.44 | 2021 | |
| Glaukos Corporation | $145.64 | 2024 | Idose |
| Rayner Intraocular Lenses Limited | $27.21 | 2025 | Rayner Cataract Set 1, Rayone Aspheric, Rayone Emv |
| Bausch & Lomb Americas INC. | $23.36 | 2022 | |
| Aerie Pharmaceuticals, INC. | $16.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Webel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.